2016-09-12 16:02:42 UTC

Sept. 13, 2016

$20 million in prizes will be awarded to develop new, innovative laboratory diagnostic tools that detect and distinguish antibiotic resistant bacteria.

The National Institutes of Health (NIH) has announced a federal prize competition calling for innovative ideas for rapid, point-of-care laboratory diagnostic tests to combat the development and spread of drug-resistant bacteria.

The Antimicrobial Resistance Diagnostic Challenge will award $20 million in prizes over all phases of the competition for new, innovative and novel laboratory diagnostic tests. The diagnostic tests being sought are those that identify and characterize antibiotic resistant bacteria and those that distinguish between viral and bacterial infections to reduce unnecessary uses of antibiotics, a major cause of drug resistance.

The prize is sponsored by two U.S. Department of Health and Human Services components, NIH and the HHS Office of the Assistant Secretary for Preparedness and Response in support of the National Action Plan for Combating Antibiotic Resistant Bacteria.

Concepts must be submitted by Jan. 9, 2017, for the first phase of the competition. More information about requirements and the timeline for awards is available in this NIH announcement.

More on Gut microbiome